184 related articles for article (PubMed ID: 23358696)
1. The role of potassium channel activation in celecoxib-induced analgesic action.
Mi Y; Zhang X; Zhang F; Qi J; Gao H; Huang D; Li L; Zhang H; Du X
PLoS One; 2013; 8(1):e54797. PubMed ID: 23358696
[TBL] [Abstract][Full Text] [Related]
2. Tannic acid modulates excitability of sensory neurons and nociceptive behavior and the Ionic mechanism.
Zhang X; Zhang H; Zhou N; Xu J; Si M; Jia Z; Du X; Zhang H
Eur J Pharmacol; 2015 Oct; 764():633-642. PubMed ID: 26134502
[TBL] [Abstract][Full Text] [Related]
3. Celecoxib and ion channels: a story of unexpected discoveries.
Frolov RV; Singh S
Eur J Pharmacol; 2014 May; 730():61-71. PubMed ID: 24630832
[TBL] [Abstract][Full Text] [Related]
4. Characteristics and molecular basis of celecoxib modulation on K(v)7 potassium channels.
Du XN; Zhang X; Qi JL; An HL; Li JW; Wan YM; Fu Y; Gao HX; Gao ZB; Zhan Y; Zhang HL
Br J Pharmacol; 2011 Nov; 164(6):1722-37. PubMed ID: 21564087
[TBL] [Abstract][Full Text] [Related]
5. Celecoxib blocks cardiac Kv1.5, Kv4.3 and Kv7.1 (KCNQ1) channels: effects on cardiac action potentials.
Macías A; Moreno C; Moral-Sanz J; Cogolludo A; David M; Alemanni M; Pérez-Vizcaíno F; Zaza A; Valenzuela C; González T
J Mol Cell Cardiol; 2010 Dec; 49(6):984-92. PubMed ID: 20858500
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxic effect of 2, 5-dimethyl-celecoxib as a structural analog of celecoxib on human colorectal cancer (HT-29) cell line.
Nikanfar S; Atari-Hajipirloo S; Kheradmand F; Rashedi J; Heydari A
Cell Mol Biol (Noisy-le-grand); 2018 May; 64(7):8-13. PubMed ID: 29974839
[TBL] [Abstract][Full Text] [Related]
7. Activation of Neuronal Voltage-Gated Potassium Kv7/KCNQ/M-Current by a Novel Channel Opener SCR2682 for Alleviation of Chronic Pain.
Wang J; Liu Y; Hu F; Yang J; Guo X; Hou X; Ju C; Wang K
J Pharmacol Exp Ther; 2021 Apr; 377(1):20-28. PubMed ID: 33431609
[TBL] [Abstract][Full Text] [Related]
8. Celecoxib inhibits Na+ currents in rat dorsal root ganglion neurons.
Park SY; Kim TH; Kim HI; Shin YK; Lee CS; Park M; Song JH
Brain Res; 2007 May; 1148():53-61. PubMed ID: 17359944
[TBL] [Abstract][Full Text] [Related]
9. Implication of K
Vicente-Baz J; Lopez-Garcia JA; Rivera-Arconada I
J Pharmacol Exp Ther; 2019 Sep; 370(3):472-479. PubMed ID: 31235533
[TBL] [Abstract][Full Text] [Related]
10. Vascular KCNQ (Kv7) potassium channels as common signaling intermediates and therapeutic targets in cerebral vasospasm.
Mani BK; O'Dowd J; Kumar L; Brueggemann LI; Ross M; Byron KL
J Cardiovasc Pharmacol; 2013 Jan; 61(1):51-62. PubMed ID: 23107868
[TBL] [Abstract][Full Text] [Related]
11. Huwentoxin-XVI, an analgesic, highly reversible mammalian N-type calcium channel antagonist from Chinese tarantula Ornithoctonus huwena.
Deng M; Luo X; Xiao Y; Sun Z; Jiang L; Liu Z; Zeng X; Chen H; Tang J; Zeng W; Songping Liang
Neuropharmacology; 2014 Apr; 79():657-67. PubMed ID: 24467846
[TBL] [Abstract][Full Text] [Related]
12. Kv7 potassium channels in airway smooth muscle cells: signal transduction intermediates and pharmacological targets for bronchodilator therapy.
Brueggemann LI; Kakad PP; Love RB; Solway J; Dowell ML; Cribbs LL; Byron KL
Am J Physiol Lung Cell Mol Physiol; 2012 Jan; 302(1):L120-32. PubMed ID: 21964407
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of Kv2.1 channel inhibition by celecoxib--modification of gating and channel block.
Frolov RV; Bondarenko VE; Singh S
Br J Pharmacol; 2010 Jan; 159(2):405-18. PubMed ID: 20015088
[TBL] [Abstract][Full Text] [Related]
14. COX-2 inhibition is neither necessary nor sufficient for celecoxib to suppress tumor cell proliferation and focus formation in vitro.
Chuang HC; Kardosh A; Gaffney KJ; Petasis NA; Schönthal AH
Mol Cancer; 2008 May; 7():38. PubMed ID: 18485224
[TBL] [Abstract][Full Text] [Related]
15. Modulation of K(v)7 potassium channels by a novel opener pyrazolo[1,5-a]pyrimidin-7(4H)-one compound QO-58.
Zhang F; Mi Y; Qi JL; Li JW; Si M; Guan BC; Du XN; An HL; Zhang HL
Br J Pharmacol; 2013 Feb; 168(4):1030-42. PubMed ID: 23013484
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of Kv7/M Channel Currents by Fangchinoline.
Li H; Geng D; Zheng R; Wang R; Li Y; Liu Y; Jia Q; Zhang F
Pharmacology; 2023; 108(2):138-146. PubMed ID: 36516801
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of HERG potassium channels by celecoxib and its mechanism.
Frolov RV; Ignatova II; Singh S
PLoS One; 2011; 6(10):e26344. PubMed ID: 22039467
[TBL] [Abstract][Full Text] [Related]
18. Dehydrocrenatidine Inhibits Voltage-Gated Sodium Channels and Ameliorates Mechanic Allodia in a Rat Model of Neuropathic Pain.
Zhao F; Tang Q; Xu J; Wang S; Li S; Zou X; Cao Z
Toxins (Basel); 2019 Apr; 11(4):. PubMed ID: 31003411
[No Abstract] [Full Text] [Related]
19. The analgesic action of larixyl acetate, a potent TRPC6 inhibitor, in rat neuropathic pain model induced by spared nerve injury.
Wang J; Zhao M; Jia P; Liu FF; Chen K; Meng FY; Hong JH; Zhang T; Jin XH; Shi J
J Neuroinflammation; 2020 Apr; 17(1):118. PubMed ID: 32299452
[TBL] [Abstract][Full Text] [Related]
20. Effects of celecoxib on voltage-gated calcium channel currents in rat pheochromocytoma (PC12) cells.
Zhang Y; Tao J; Huang H; Ding G; Cheng Y; Sun W
Pharmacol Res; 2007 Sep; 56(3):267-74. PubMed ID: 17719233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
